| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 716 | 2021 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 196 | 2021 |
| Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort JL Calleja, J Crespo, D Rincón, B Ruiz-Antorán, I Fernandez, C Perelló, ... Journal of hepatology 66 (6), 1138-1148, 2017 | 189 | 2017 |
| Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ... Nature communications 6 (1), 6422, 2015 | 176 | 2015 |
| Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver M Rojas-Feria, M Castro, E Suárez, J Ampuero, M Romero-Gómez World journal of gastroenterology: WJG 19 (42), 7327, 2013 | 176 | 2013 |
| Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis J Ampuero, R Pais, R Aller, R Gallego-Durán, J Crespo, C García-Monzón, ... Clinical Gastroenterology and Hepatology 18 (1), 216-225. e5, 2020 | 147 | 2020 |
| miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis CH Liu, J Ampuero, A Gil-Gómez, R Montero-Vallejo, Á Rojas, ... Journal of hepatology 69 (6), 1335-1348, 2018 | 146 | 2018 |
| Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis J Ampuero, M Simón, C Montoliú, R Jover, MÁ Serra, J Córdoba, ... Gastroenterology 149 (6), 1483-1489, 2015 | 145 | 2015 |
| HCV genotype 3–the new treatment challenge J Ampuero, M Romero‐Gomez, KR Reddy Alimentary pharmacology & therapeutics 39 (7), 686-698, 2014 | 141 | 2014 |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 140 | 2022 |
| Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis J Ampuero, R Gallego-Durán, M Romero-Gómez Rev Esp Enferm Dig 107 (1), 10-6, 2015 | 135 | 2015 |
| Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis SM Borgia, J Dearden, EM Yoshida, SD Shafran, A Brown, Z Ben-Ari, ... Journal of hepatology 71 (4), 660-665, 2019 | 126 | 2019 |
| Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ... Journal of hepatology 75 (4), 786-794, 2021 | 119 | 2021 |
| Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry I Medina-Caliz, M Garcia-Cortes, A Gonzalez-Jimenez, MR Cabello, ... Clinical Gastroenterology and Hepatology 16 (9), 1495-1502, 2018 | 108 | 2018 |
| The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity J Ampuero, R Aller, R Gallego‐Durán, JM Banales, J Crespo, ... Alimentary pharmacology & therapeutics 48 (11-12), 1260-1270, 2018 | 107 | 2018 |
| Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver … S Petta, G Sebastiani, M Viganò, J Ampuero, VWS Wong, J Boursier, ... Clinical gastroenterology and hepatology 19 (4), 806-815. e5, 2021 | 103 | 2021 |
| Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH J Ampuero, R Aller, R Gallego-Durán, J Crespo, JL Calleja, ... Journal of Hepatology 73 (1), 17-25, 2020 | 92 | 2020 |
| FibroGENE: A gene-based model for staging liver fibrosis M Eslam, AM Hashem, M Romero-Gomez, T Berg, GJ Dore, A Mangia, ... Journal of hepatology 64 (2), 390-398, 2016 | 85 | 2016 |
| Metformin inhibits glutaminase activity and protects against hepatic encephalopathy J Ampuero, I Ranchal, D Nunez, MM Díaz-Herrero, M Maraver, JA Campo, ... PLoS One 7 (11), e49279, 2012 | 83 | 2012 |
| Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease J Ampuero, M Rojas‐Feria, M Castro‐Fernández, C Cano, ... Journal of gastroenterology and hepatology 29 (2), 291-295, 2014 | 58 | 2014 |
